Zydus Lifesciences Ltd (ZYDUSLIFE)
🎯 Key Takeaways
- Revenue grew 5.7% QoQ to ₹8,017 in Q1FY27.
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 6,123 | 6,865 | 7,587 | 8,017 |
| Operating Profit | 1,714 | 1,457 | 2,046 | 1,375 |
| OPM % | 28.0% | 21.2% | 27.0% | 17.1% |
| Net Profit | 1,233 | 965 | 1,341 | 952 |
| EPS | ₹12.51 | ₹10.36 | ₹12.65 | ₹9.35 |
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 101 | 101 | 101 | 101 |
| Reserves | 21,724 | 23,853 | 25,201 | 27,011 |
| Borrowings | 191 | 3,213 | 9,636 | 11,770 |
| Total Liabilities | 31,446 | 37,202 | 46,897 | 52,407 |
| Fixed Assets | 6,102 | 6,042 | 7,099 | 26,639 |
| Investments | 2,596 | 6,408 | 5,878 | 7,540 |
| Total Assets | 31,446 | 37,202 | 46,897 | 52,407 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +2,117 |
| Investing | -8,296 |
| Financing | +5,807 |
| Net Cash Flow | -373 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 75.0% | 75.0% | 75.0% | 75.0% |
| FII | 7.3% | 7.1% | 7.0% | 6.9% |
| DII | 10.9% | 11.1% | 11.2% | 11.3% |
| Public | 5.5% | 5.5% | 5.5% | 5.5% |
| # Shareholders | 3,96,105 | 4,03,266 | 4,18,314 | 3,99,251 |
⚖️ Peer Comparison — Pharmaceuticals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| SUNPHARMA | 4.61 L Cr | 38.1 | 18.7% | 14.6% | 0.05 |
| DIVISLAB | 2.46 L Cr | 84.1 | 23.0% | 17.4% | 0.00 |
| TORNTPHARM | 1.92 L Cr | 80.3 | 15.1% | 25.7% | 1.76 |
| ZYDUSLIFE | 1.18 L Cr | 26.4 | 16.8% | 16.6% | 0.43 |
| CIPLA | 1.15 L Cr | 34.0 | 13.2% | 9.8% | 0.01 |
| LAURUSLABS | 1.05 L Cr | 95.5 | 20.8% | 20.6% | 0.45 |
| LUPIN | 99,448 | 17.6 | 27.9% | 24.7% | 0.26 |
| MANKIND | 98,599 | 48.2 | 13.9% | 12.7% | 0.38 |
| DRREDDY | 98,308 | 30.4 | 10.1% | 8.4% | 0.17 |
| AUROPHARMA | 94,937 | 25.8 | 12.8% | 9.8% | 0.20 |
🔗 Peer Stock Analyses
📋 Recent Filings
-
🟡 related party transaction 26 August 2026Zydus Lifesciences announced incorporation of wholly owned subsidiary Zydus Global Treasury Centre IFSC Limited in Gandhinagar, Gujarat, with Rs. 5 cr...
-
🔴 Insider Trading 24 August 2026Zydus Lifesciences disclosed that Prashant Patel of the promoter group received 32,577 shares via transmission from his late mother Jasodaben Patel, a...
-
Announcement 23 August 2026Zydus Lifesciences announced an investor conference from August 24-26, 2026, showcasing its financial performance and growth strategy. The company rep...
-
🔴 Financial Results 18 August 2026Zydus Lifesciences reported consolidated revenue of ₹80.2 billion, up 22% YoY, driven by 20% growth in India pharmaceuticals, 34% in international mar...
-
Announcement 17 August 2026Zydus Lifesciences announced an investor roadshow in Singapore and Hong Kong from August 24-26, 2026, to engage institutional investors ahead of poten...
-
Announcement 12 August 2026Zydus Lifesciences announced that its scheduled participation in the Motilal Oswal Global Investor Conference, originally set for August 18, 2026, has...
-
🔴 Financial Results 11 August 2026Zydus Lifesciences reported Q1 FY27 revenue of **₹80,170 crores**, up 22% YoY, but net profit fell 36% to **₹9,398 crores** due to margin pressure. EB...
-
🟡 Board Meeting 11 August 2026Zydus Lifesciences announced its Q1 FY2026 unaudited financial results approved on August 11, 2026, showing consolidated revenue of INR 28,722 million...
-
🔴 Insider Trading 11 August 2026Zydus Lifesciences disclosed an insider trading violation by Designated Person Ashutosh Patil, who inadvertently bought 171 shares on March 11 and May...
-
🟡 Board Meeting 11 August 2026Zydus Lifesciences reappointed Dr. Sharvil Patel as Managing Director for five years starting April 1, 2027, and appointed Kulin Lalbhai as an Indepen...
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ZYDUSLIFE files new disclosures
Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ZYDUSLIFE — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd